CLDN5: A Potential Drug Target and Biomarker (G7122)

Target Name: CLDN5

NCBI ID: G7122

CLDN5

CLDN5: A Potential Drug Target and Biomarker

CLDN5 (Clone deletions in the long non-coding RNA 5 gene) is a variant of the long non-coding RNA 5 gene that has been identified as a potential drug target or biomarker. CLDN5 is a unique gene that has been shown to be involved in the regulation of cell adhesion, and studies have suggested that it may play a role in the development and progression of various diseases.

The long non-coding RNA 5 gene is a member of the cluster of genes known as the HOX gene family, which is involved in the regulation of gene expression and development. The HOX genes are characterized by the presence of a specific DNA binding site that is responsible for the regulation of gene expression.

CLDN5 is a unique variant of the long non-coding RNA 5 gene because it has been shown to have altered levels of gene expression compared to the wild-type gene. Studies have shown that CLDN5 has been shown to have decreased levels of mRNA and protein expression compared to the wild-type gene.

One of the potential reasons for the altered levels of gene expression in CLDN5 is the presence of gene variants or mutations that have been identified in the gene. Studies have shown that CLDN5 is prone to mutations, including missense mutations, which can alter the structure and function of the gene.

Another potential mechanism for the altered levels of gene expression in CLDN5 is the presence of RNA processing defects. Studies have shown that CLDN5 has been shown to have reduced levels of RNA stability, which may be a result of defects in the RNA processing pathway.

In conclusion, CLDN5 is a unique variant of the long non-coding RNA 5 gene that has been shown to have altered levels of gene expression and potential drug targets. Further studies are needed to fully understand the role of CLDN5 in the regulation of cell adhesion and the development and progression of various diseases.

Protein Name: Claudin 5

Functions: Plays a major role in tight junction-specific obliteration of the intercellular space

The "CLDN5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLDN5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets